Atticus Wealth Management’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
Other funds holding MDT
LMFP
FWIA
DC
GI
MAA
CGH
CNB
Atticus Wealth Management's MDT Position: Q2 2026 in Review
Atticus Wealth Management reduced its Medtronic (MDT) stake by 18% in Q2 2026, selling an estimated $93.8K and leaving 5,391 shares worth $422K. The position accounts for 0.1% of the portfolio, ranked #123.
Atticus Wealth Management first reported a position in MDT in Q4 2019 and has held it in 20 quarters since. The position peaked at $627K in Q4 2025. 372 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- Atticus Wealth Management held 5,391 shares of Medtronic worth $422K as of Q2 2026.
- Atticus Wealth Management sold 1,163 Medtronic shares in Q2 2026, an estimated $93.8K.
- Medtronic made up 0.1% of Atticus Wealth Management's portfolio in Q2 2026, its #123 holding.
- Atticus Wealth Management first reported a position in Medtronic in Q4 2019 and has held it in 20 quarters since.
- Atticus Wealth Management's Medtronic position peaked at $627K in Q4 2025.
- 372 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on Atticus Wealth Management's 13F filing for Q2 2026, filed 15 Jul 2026.